Hansen Gwenn bought NRIX
October 14, 2025 · Form 4 insider transaction
Hansen Gwenn bought 20,000 shares of Nurix Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 9 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderHansen Gwenn
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateOctober 14, 2025
Filing dateOctober 23, 2025
Shares owned after20,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.; The RSUs will vest on the second anniversary of the date of grant, subject to the Reporting Person's continuous services to the Issuer from the date of grant through such vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.; RSUs do not expire; they either vest or are canceled prior to the vest date.